PubRank

K N Von Kaulla

Author PubWeight™ 15.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Changes in blood coagulation. Arch Surg 1966 3.22
2 Antithrombin 3 and diseases. Am J Clin Pathol 1967 1.39
3 Antithrombin 3 depression and thrombin generation acceleration in women taking oral contraceptives. Am J Obstet Gynecol 1971 1.34
4 Blood coagulation in uremic patients before and after hemodialysis and transplantation of the kidney. Arch Surg 1966 1.22
5 Effect of aspirin in amaurosis fugax. Lancet 1972 1.06
6 The extraction of vascular plasminogen activator from human cadavers and a description of some of its properties. Am J Clin Pathol 1971 0.98
7 Human serum plasminogen antiactivator: its distinction from antiplasmin. Am J Physiol 1971 0.94
8 Dissimilarity of human vascular plasminogen activator and human urokinase. J Lab Clin Med 1971 0.94
9 Isolation of lipids from plasma by affinity chromatography. Biochem Biophys Res Commun 1973 0.88
10 Urinary procoagulant excretion in experimental renal disease. Proc Soc Exp Biol Med 1968 0.84
11 Procoagulant content of human urine in health and disease. Am J Clin Pathol 1968 0.79
12 Transient monocular blindness and increased platelet aggregability treated with aspirin. A case report. Neurology 1972 0.78
13 The procoagulant in human urine: purification, assay and some biochemical and physiological properties. Thromb Diath Haemorrh 1966 0.77
14 Structure-dependent inhibition by synthetic fibrinolytic anions of collagen-induced aggregation of human platelets. J Med Chem 1970 0.76
15 Reduced excretion of urinary procoagulant in uremic patients. Experientia 1966 0.75
16 Animal plasma as substrate for synthetic fibrinolysis inducers. Proc Soc Exp Biol Med 1966 0.75
17 [The coagulation component in human urine: its purification, properties, form of secretion in health and disease and its effect on animals]. Prensa Med Argent 1966 0.75
18 Beta 1 C-globulin and synthetic fibrinolytic agents. Proc Soc Exp Biol Med 1969 0.75
19 A serial micro-fibrinolysis test and its use in rats with liver-bypass. Thromb Diath Haemorrh 1966 0.75
20 Letter: Thrombolytic agents: are suitable methods used for their assessment? Are our investigative efforts directed toward the right goal? Thromb Res 1974 0.75
21 Prevention of dog serum-induced aggregation of pig platelets. Proc Soc Exp Biol Med 1972 0.75
22 Factor 8 activity in haemophkilic plasma unmasked by synthetic organic anions. Nat New Biol 1972 0.75
23 Letter: In-vitro dissolution of human clots. Lancet 1975 0.75
24 Niflumic acid, prototype of a multiaction antithrombotic agent. Experientia 1974 0.75
25 Clotting abnormalities following orthotopic and heterotopic transplantation of marginally preserved pig livers. Acta Hepatosplenol 1971 0.75
26 Preoperative correction of coagulation in tetralogy of Fallot. Arch Surg 1967 0.75
27 Synthetic activators of fibrinolysis which possess anticoagulant property. Experientia 1965 0.75